Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors inside the central nervous technique, conolidine modulates alternate molecular targets. A Science Innovations study located that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regu… Read More